Mutagenesis of the GABA rho 1 receptor alters agonist affinity and channel gating.
Seventeen site-directed mutations were constructed in the GABA rho 1 receptor with the aim of finding agonist binding domains common to rho 1 and rho 2 receptors but distinct from those identified in members of the family of homologous, ligand gated ion channels. Mutated cDNAs were expressed in Xenopus oocytes and tested by voltage clamp experiments. Five of the mutations abolished responsiveness to GABA. Mutation Q189H, in the conserved cysteine loop, diminished apparent GABA affinity to about 1/10 of wild type values in a manner consistent with decreased allosteric cooperativity among agonist recognition sites. Mutation R316A, located in the extracellular loop between transmembrane domains II and III, increased the Hill coefficient to 3.9 in a fashion consistent with enhanced open probability of a receptor multimer.
Kusama
T
T
Molecular Neurobiology Branch, National Institute on Drug Abuse, Baltimore, MD 21224.
Wang
J B
JB
Spivak
C E
CE
Uhl
G R
GR
D000595:Amino Acid Sequence; D000818:Animals; D018076:DNA, Complementary / Q000235:genetics / Q000378:metabolism; D005260:Female; D018755:GABA Agonists / Q000378:metabolism*; D015640:Ion Channel Gating / Q000187:drug effects* / Q000235:genetics*; D007700:Kinetics; D008564:Membrane Potentials / Q000502:physiology; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D009841:Oligonucleotides / Q000138:chemical synthesis; D018079:Receptors, GABA / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D014981:Xenopus
D018076:DNA, Complementary; D018755:GABA Agonists; D009841:Oligonucleotides; D018079:Receptors, GABA